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Abstract
Background: Sustained hyperglycemia is a known risk factor for adverse outcomes in critically ill patients.
The specific aim was to determine if a nurse initiated insulin infusion protocol (IIP) was effective in
maintaining blood glucose values (BG) within a target goal of 100–150 mg/dL across different intensive care
units (ICUs) and to describe glycemic control during the 48 hours after protocol discontinuation.
Methods: A descriptive, retrospective review of 366 patients having 28,192 blood glucose values in three
intensive care units, Surgical Trauma Intensive Care Unit (STICU), Medical (MICU) and Coronary Care
Unit (CCU) in a quaternary care hospital was conducted. Patients were > 15 years of age, admitted to
STICU (n = 162), MICU (n = 110) or CCU (n = 94) over 8 months; October 2003-June 2004 and who had
an initial blood glucose level > 150 mg/dL. We summarized the effectiveness and safety of a nurse initiated
IIP, and compared these endpoints among STICU, MICU and CCU patients.
Results: The median blood glucose values (mg/dL) at initiation of insulin infusion protocol were lower in
STICU (188; IQR, 162–217) than in MICU, (201; IQR, 170–268) and CCU (227; IQR, 178–313); p < 0.0001.
Mean time to achieving a target glucose level (100–150 mg/dL) was similar between the three units: 4.6
hours in STICU, 4.7 hours in MICU and 4.9 hours in CCU (p = 0.27). Hypoglycemia (BG < 60 mg/dL)
occurred in 7% of STICU, 5% of MICU, and 5% of CCU patients (p = 0.85). Protocol violations were
uncommon in all three ICUs. Mean blood glucose 48 hours following IIP discontinuation was significantly
different for each population: 142 mg/dL in STICU, 167 mg/dL in MICU, and 160 mg/dL in CCU (p <
0.0001).
Conclusion: The safety and effectiveness of nurse initiated IIP was similar across different ICUs in our
hospital. Marked variability in glucose control after the protocol discontinuation suggests the need for
further research regarding glucose control in patients transitioning out of the ICU.
Published: 29 August 2007
BMC Emergency Medicine 2007, 7:14 doi:10.1186/1471-227X-7-14
Received: 19 January 2007
Accepted: 29 August 2007
This article is available from: http://www.biomedcentral.com/1471-227X/7/14
© 2007 Barth et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Emergency Medicine 2007, 7:14 http://www.biomedcentral.com/1471-227X/7/14
Page 2 of 9
(page number not for citation purposes)
Background
Sustained hyperglycemia is a known risk factor for adverse
outcomes in the critically ill patient, whether or not the
patient has a history of diabetes mellitus [1-3]. There are
many factors that affect glycemic control; metabolic
derangement and counter-regulation, increased stress,
decrease insulin (resistance or underproduction),
increased glucose administration just to name a few [4,5].
Although short term glycemic increases related to stress
are not associated with rise in mortality in all populations
[1,6,7].
Intensive insulin therapy is emerging as a treatment
modality. At the time of our study, other than cardiovas-
cular surgery patients [1,8,9], it was uncertain what spe-
cific patient populations benefit from intensive insulin
therapy. Other populations are beginning to emerge in
the literature [7]; trauma patients [10,11], intraoperative
[12], and medical patients [13,14].
Despite some uncertainties, the management of hypergly-
cemia utilizing insulin protocols is fast becoming a new
standard in critical care practice [1,13-23]. Nurse initiated
protocols generally have been found to improve patient
care [13,17,22], limit the prescribing variability
[15,16,18,20,24] and contribute to financial cost savings
[17]. However it is unknown if a nurse initiated IIP is
effective and safe across different ICU populations. Also,
it appears similar protocols in different populations'
yields different clinical outcomes [9,14]. It is unclear if the
protocol or operation of the protocol leads in part to these
differences.
In this study we sought to determine if the IIP was effec-
tive and safe in bringing blood glucose values within the
target range of 100–150 mg/dL among the three different
ICUs (surgical, medical and coronary care). We were also
interested in glycemic control across different ICU popu-
lations in the first 48 hours after the IIP was discontinued,
when the patients transition out of the ICU.
Methods
Design
We conducted a descriptive retrospective review of 366
patients having 28,192 blood glucose values in the analy-
sis of outcomes after Mayo Foundation Institutional
Review Board (IRB) approval was granted. Patients had
been cared for in one of three ICUs in a quaternary care
hospital at Mayo Clinic Rochester, MN where an intensive
insulin protocol was utilized. The ICUs included a 24-bed
Surgical Trauma Intensive Care Unit (STICU), a 24-bed
Medical ICU (MICU), and a 16-bed Coronary Care Unit
(CCU).
Patients
Inclusion criteria included adult patients, 15 years of age
and older, admitted to STICU, MICU or CCU who had a
blood glucose level greater than 150 mg/dL while on the
unit and were placed on an IIP during the identified data
collection time frame October 2003-June 2004. 366 out
of 386 eligible patients were used for data analysis. Eight-
een patients were excluded since they did not grant
approval for use of their data for research purposes. One
patient was not started on insulin drip and one was on a
modified insulin drip prior to ICU admission. There were
not any other exclusion criteria. Patients readmitted to the
ICU during the same or subsequent hospitalization were
Table 1: Patient characteristics
STICU (n = 162) MICU (n = 110) CCU (n = 94) p Value
Age, mean (SD) 59.9 (19.5) 61.4 (17.6) 67.8 (12.7) 0.01
Gender, Female, n (%) 79 (49) 57 (52) 35 (37) 0.09
Weight, kg, mean (SD) 90.5 (32.9) 84.7 (25.8) 87.4 (23.0) 0.70
Height, cm, mean (SD) 169.0 (9.6) 167.4 (19.4) 170.5 (10.2) 0.44
Diabetes, n (%) 48 (30) 47 (43) 57 (61) < 0.0001
Medications
IV/Oral 
Corticosteroids, n (%)
34 (21) 51 (46) 9 (10) < 0.0001
Epinephrine/
Norepinephrine, n (%)
13 (8) 16 (15) 14 (15) 0.14
Beta blockers, n (%) 57 (35) 25 (23) 52 (55) < 0.0001
APACHE III score, mean 
(SD)
n = 158
52.7 (21.9)
n = 109
67.3 (30.1)
n/a < 0.0001
ICU LOS, days, median 
(IQR)
6.4 (3.3–13.2) 2.9 (1.3–8.7) 2.4 (1.3–4.2) < 0.001
ICU mortality, n (%) 8 (5) 16 (15) 15 (16) 0.004
Hospital mortality, n (%) 12 (7) 21 (19) 25 (27) < 0.001
ICU, Intensive Care Unit; STICU, Surgical Trauma ICU; MICU, Medical ICU; CCU, Coronary Care Unit; APACHE, Acute Physiological and Chronic 
Health Evaluation; n/a, not available; LOS, length of stay; IQR, interquartile rangeBMC Emergency Medicine 2007, 7:14 http://www.biomedcentral.com/1471-227X/7/14
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not considered for analysis. Patient characteristics are
summarized in Table 1.
Interventions
Intensive Insulin Infusion Protocol for Insulin Therapy
A 4-column, non-calculated protocol for continuous
intravenous insulin administration (measured in units/
hour) on adult patients was initiated by the RN with
blood glucose value greater than 150 mg/dL [see Addi-
tional file 1].
Glucose Meter for Blood Sampling
Blood glucose values collected by vascular access team
(VAT) laboratory personnel, obtained by capillary "finger-
stick", arterial or venous blood draw (measured in mg/dL)
were measured via one of three methods: 1) Bedside glu-
cose values were measured using a standard hospital glu-
cose meter (SureStep Flexx; Lifescan, Johnson & Johnson,
New Brunswick, NJ). 2) Serum glucose values were meas-
ured using a standard hospital glucose instrument (Mod-
ular Roche Hitachi, Japan, Roche Corporation,
Indianapolis, IN). 3) Plasma glucose values were meas-
ured using a standard hospital glucose instrument (Beck-
man Glucose Analyzer 2, Beckman Coulter, Brea, CA). It
is estimated that 80% of blood glucose values were
obtained by capillary, 19% by arterial and 1% by venous
blood draw.
Definitions
Time to achieve goal: hours until first blood glucose value ≤
150 mg/dL
Safety: percent of blood glucose values ≥ 60 mg/dL
Hyperglycemic: blood glucose > 150 mg/dL
Hypoglycemic: blood glucose < 60 mg/dL
Mean Percent: Reflects the average per-patient percent of
blood glucose values meeting a specified criterion (e.g.
values > 150 or < 60 mg/dL, falling outside the target IIP
range), computed from the data from all individuals in
the group of interest. To compute this value, the total
number of blood glucose values meeting the criterion for
a given patient were summed up, divided by the total
number of blood glucose measurements, and multiplied
by 100. The mean percent was then computed as the sim-
ple average of the per-patient percentages for all subjects
in the group of interest. This measure was used to reflect
the total proportion of the time that study participants
had blood glucose measurements outside the targeted IIP
range.
Procedure
At our institution, following the publication of the Van
den Berghe study [1], a group of nurses and pharmacists
began exploring a project to examine if use of the IIP
would make a difference in patient populations other
than cardiovascular surgery. A recent pilot study was done
on two cardiovascular surgery ICUs utilizing the RN initi-
ated IIP which they adapted from a published protocol
[15]. STICU, MICU and CCU ICU populations were uti-
lized to determine if IIP would work similarly in different
patient populations. Input and feedback were gathered
related to management of patients on insulin. Collabora-
tion with RNs, physicians & pharmacists identified need
for better control of critically ill patient blood glucose lev-
els and support was obtained from physician leadership
of each ICU. Since the IIP was a new protocol being uti-
lized in STICU, MICU and CCU, staff registered nurses
(RNs) were educated prior to implementation. Data col-
lection began one month after education.
A target goal range of 100–150 mg/dL was established for
our institutions IIP. Caution to avoid hypoglycemia was
one factor that contributed to this range. This factor has
been documented in the literature for other institutions as
well. Total elimination of hypoglycemia is a desirable but
difficult to achieve expectation of critically ill patients due
to the confounding factors that contribute to their illness.
Our institution has a hypoglycemic protocol to treat
patients whose blood glucose falls below 60 mg/dL.
Frequency of blood glucose measurements was deter-
mined by the IIP. Hourly values were obtained until the
patient was in goal range for 4 continuous hours, and then
the frequency was decreased to every two hours. Return to
hourly monitoring occurred with the following identified
situations: change in nutritional or clinical status, blood
glucose above goal range for 2 consecutive readings or
blood glucose below 100 mg/dL.
Additional investigator developed tools utilized for data
collection included an IIP Data Collection Tool (completed
by the staff RN) and an IIP Clinical Nurse Specialist (CNS)/
Nursing Education Specialist (NES) Data Collection Tool
which was completed after the protocol was discontinued.
The IIP was discontinued at the time the patient trans-
ferred out to a general care floor, when ICU care was no
longer deemed necessary. One investigator was present on
each unit at least 5 days of the week to answer questions
& clarify use of protocol during the data collection period.
Generally, in the 48 hours after protocol discontinuation,
blood glucose monitoring continued at a lower frequency
(2–4 times daily) based on glucose values, clinical situa-
tions or symptoms. There was variability in treatment
ranging from higher goal insulin infusion (not IIP), sub-
cutaneous insulin regimens, oral diabetic agents, or noBMC Emergency Medicine 2007, 7:14 http://www.biomedcentral.com/1471-227X/7/14
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treatment. Patient follow-up was determined by the pri-
mary physician service.
Statistical analysis
Summary patient features, reported in Table 1, were calcu-
lated for each of the three care units using means (stand-
ard deviations), or median (interquartile range) or count
(percentage) as appropriate for the data. These variables
were compared among the three units using chi-square
tests for categorical data, and Kruskal-Wallis tests for con-
tinuous data. Comparisons of blood glucose decline
among the units are shown by the profile plots in Figures
1, 2, 3. These figures were generated using a mixed model
analysis of variance. Specifically, the blood glucose level
was modeled as a quadratic function of time (days) on
insulin infusion taking into account the type of ICU and
the serial aspect of the data. All blood glucose measure-
ments from 2 hours prior to drip start until the order dis-
continuation time was used for data modeling. To
decrease the influence of patients with prolonged ICU
stay, any patient who underwent insulin infusion for
more than 100 hours had their last measure truncated at
100 hours. As within patient blood glucose measurements
could decrease over a wide range, say from 400 mg to 100
mg; a natural logarithm transformation to stabilize the
variability of blood glucose was employed. The fitted data
was examined for a quadratic association with time by
inspecting the graphs which indicated that a quadratic
association with time provided a reasonable fit to the
data. The final model includes linear and quadratic terms
for time, and an indicator variable for ICU type and the
interactions between time and ICU type. Thus, the result-
ing models are multiplicative and curvilinear, meaning
that a day on infusion results in a percent decrease in
blood glucose but the decrease changes over days. Meas-
urements of blood glucose which were made repeatedly
over time were summarized by calculating the patients'
mean blood glucose, during a specific interval, and calcu-
lating a series of box plots for each unit (Figures 4, 5, 6).
The box plots indicate the distribution of the individual
patient means. In addition to examining data collected
during the IIP, measures of blood glucose obtained in the
48 hours following IIP were obtained, summarized and
compared among units in the same manner as described
for the data collected during the use of the IIP. The SAS
statistical software (SAS Institute Inc, Cary NC) was used
for all analyses, and two-sided p values < 0.05 were con-
sidered to be statistically significant.
Results
Three hundred and sixty-six patients met inclusion criteria
over the eight months of the study period, 162 in STICU,
110 in MICU and 94 in the CCU. General patient charac-
teristics are listed in Table 1. The average length of ICU
stay, and the duration of IIP infusion varied, with STICU
being the longest. The number of blood glucose measure-
ments obtained while on the IIP compared to the 48
hours after IIP discontinuation were 13,120 (average 81
per patient)/1,926 in STICU, 6,639 (60 per patient)/1,322
in MICU, and 4,199/986 (45 per patient) in CCU. The
total blood glucose values utilized for analysis was
28,192. The median blood glucose values at initiation of
IIP were statistically different for each unit, STICU, MICU,
and CCU (Table 2). Mean insulin infusion rates, however,
were similar in all 3 units. While we observed small differ-
ences in the time-response curves and individual blood
glucose readings at the 24 hour time point, the overall
safety and efficacy of the protocol were similar in all three
ICUs (Table 2, Figures 1, 2, 3, 4, 5, 6). Deviations from the
protocol were uncommon and similar across the 3 ICUs
(Table 3).
A large percentage of patients in each of the ICUs experi-
enced hyperglycemia after the IIP was discontinued and
the patient transitioned out of the ICU. Table 4 summa-
rizes the results 48 hours after the IIP discontinuation.
Discussion
To our knowledge, this is one of the first studies to com-
pare use of a non-calculating insulin infusion protocol in
Individual profiles of blood glucose of patients who under- went insulin infusion-STICU Figure 1
Individual profiles of blood glucose of patients who 
underwent insulin infusion-STICU. Individual profiles of 
blood glucose of patients who underwent insulin infusion 
after admission to the STICU, n = 162 (fuchsia lines) along 
with the predicted level of blood glucose (solid line). The 
predicted level of blood glucose is based on the mathematical 
model below where time is measured in days since the start 
of insulin infusion: Blood glucose (mg/dL) = exp(5.1030 - 
0.3023*time + 0.0640*time*time).BMC Emergency Medicine 2007, 7:14 http://www.biomedcentral.com/1471-227X/7/14
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three different adult ICU patient populations. At the initi-
ation of the protocol, hyperglycemia was more severe in
medical than in surgical ICU patients. The protocol effec-
tiveness and safety were, however, similar across the three
ICUs. A large percentage of patients developed hyperglyc-
emia after IIP discontinuation.
Table 2: Summary data while on the insulin infusion protocol
STICU (n = 162) MICU (n = 110) CCU (n = 94) p Value
Blood glucose at initiation 
of IIP, median (IQR), mg/dL
188 (162–217) 201 (170–268) 227 (178–313) < .0001
Insulin infusion rates, mean 
(SE)*, ml/hr
1.7 (0.10) 1.7 (0.12) 2.0 (0.13) 0.19
Hours until BG ≤ 150 mg/
dL, mean (SD)
n = 159
4.6 (4.4)
n = 103
4.7 (4.4)
n = 89
4.9 (3.9)
0.27
Patients > 150 mg/dL @ 
time point, n (%):
12 ± 2 hours 37/158 (23) 28/96 (29) 24/82 (29) 0.49
24 ± 2 hours 18/138 (13) 13/77 (17) 20/56 (36) 0.001
36 ± 2 hours 19/117 (16) 12/60 (20) 9/40 (23) 0.63
48 ± 2 hours 15/104 (14) 12/44 (27) 6/29 (21) 0.18
Duration IIP use, days, 
mean (SD)
3.8 (3.8) 2.8 (2.7) 2.0 (2.5) < 0.0001
Patients with at least one 
blood glucose < 60 mg/dL, 
n (%)
11 (7) 6 (5) 5 (5) 0.85
Mean percent BG < 60 mg/
dL, mean (SD)
0.2 (1.4) 0.3 (1.5) 0.1 (0.6) 0.88
IQR, interquartile range; BG, blood glucose; SE, standard error
*To account for multiple values measured per person
Individual profiles of blood glucose of patients who under- went insulin infusion-MICU Figure 2
Individual profiles of blood glucose of patients who 
underwent insulin infusion-MICU. Individual profiles of 
blood glucose of patients who underwent insulin infusion 
after admission to the MICU, n = 110 (fuchsia lines) along 
with the predicted level of blood glucose (solid line). The 
predicted level of blood glucose is based on the mathematical 
model below where time is measured in days since the start 
of insulin infusion: Blood glucose (mg/dL) = exp(5.1977 - 
0.3936*time + 0.0840*time*time).
Individual profiles of blood glucose of patients who under- went insulin infusion-CCU Figure 3
Individual profiles of blood glucose of patients who 
underwent insulin infusion-CCU. Individual profiles of 
blood glucose of patients who underwent insulin infusion 
after admission to the CCU, n = 94 (fuchsia lines) along with 
the predicted level of blood glucose (solid line). The pre-
dicted level of blood glucose is based on the mathematical 
model below where time is measured in days since the start 
of insulin infusion: Blood glucose (mg/dL) = exp(5.2808 - 
0.4987*time + 0.1160*time*time).BMC Emergency Medicine 2007, 7:14 http://www.biomedcentral.com/1471-227X/7/14
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In our study, hyperglycemia in medical patients may be
attributed to a higher incidence of diabetes in CCU &
MICU as compared to STICU. In addition, there was
higher use of IV or oral corticosteroids in MICU and beta
blocker use in CCU. However, despite different starting
blood glucose values, the finding of mean time (hours)
that the patients blood glucose value first dropped to <
150 mg/dL was similar in all three units (STICU 4.6,
MICU 4.7, CCU 4.9; p = 0.27) is meaningful. This suggests
that even though the patients were located in different
ICUs (thus presuming different diagnoses); their response
to the same IIP was effective. Interestingly, the only differ-
ence in patient blood glucose > 150 mg/dL was found at
24 hours between STICU (13%), MICU (17%), and CCU
(36%); p < 0.001. Although statistically significant, this
may not be clinically significant given that approximately
half of the CCU patients were not on the IIP at 24 hours.
Between patient variability is indicated by the width of the
box plots show in Figures 4, 5, 6. For MICU (Figure 5) and
CCU (Figure 6) patients, time 0 blood glucose is highly
variable but decreases over time. STICU (Figure 4)
patients are not as variable at time 0 and have less
decrease over time.
Furthermore, mean insulin drip rates, time to goal, and
deviation from IIP all were clinically similar and not sta-
tistically significant which may suggest that patient differ-
ences, not protocol adherence, may be the contributing
factor that may account for our findings. Although we did
not look for absolute deviations, we cannot rule these out.
We also acknowledge the potential that investigators
could have biased the outcome related to deviations due
to presence on the unit. It appears that in critically ill
patients, glucose levels rather than amount of insulin
infused account for mortality benefit [25]. The Van den
Berghe study [1] found reductions in mortality and mor-
bidities attributable to mean glucose of 103 mg/dl in the
intensive treatment group compared to the more mod-
estly treated group with mean glucose value of 153 mg/dL.
Furthermore, the findings appeared most dramatic in the
patients who had ICU stays of greater than 5 days. Limita-
tions of Van den Berghe's study include questionable gen-
Table 3: Deviations from insulin infusion protocol
STICU (n = 162) MICU (n = 110) CCU (n = 94)
Started in a wrong column 27 15 15
Jumped a column 0 0 1
BG < 150 mg/dL when IIP started 4 2 1
Patients with deviation, n (%) 31 (19) 17 (15) 17 (18)
BG, blood glucose
Median & interquartile range of actual blood glucose values  of patients who underwent insulin infusion after admission- STICU Figure 4
Median & interquartile range of actual blood glucose 
values of patients who underwent insulin infusion 
after admission-STICU. The box plots indicate the distri-
bution of the individual patient means. See statistical methods 
section for details.
Median & interquartile range of actual blood glucose values  of patients who underwent insulin infusion after admission- MICU Figure 5
Median & interquartile range of actual blood glucose 
values of patients who underwent insulin infusion 
after admission-MICU. The box plots indicate the distri-
bution of the individual patient means. See statistical methods 
section for details.BMC Emergency Medicine 2007, 7:14 http://www.biomedcentral.com/1471-227X/7/14
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eralizability of results outside of the cardiac surgical
population, single center study with unclear feasibility in
a larger scope, and early aggressive glucose administration
for all patients in both treatment and control groups
which may have forced some of the hyperglycemia and
insulin dosing. However, the study has largely been
embraced as evidence for intensive insulin therapy in the
ICU.
Our patient characteristics do show a difference between
age, diabetes, steroid, and beta blocker use which may
contribute to each ICUs difference in blood glucose value
at initiation of IIP. Moreover, ICU length of stay and IIP
duration was greater in the STICU compared to MICU and
CCU. Because of this time difference, comparing mean
blood glucose values was not pertinent because of the cor-
relation to length on the IIP (the longer on the IIP, the
great chance to get into goal range). Hyperglycemia was a
risk factor in non diabetic patients admitted in cardiac,
cardiothoracic and neurosurgical ICUs, however not in
medical or general surgical ICUs [7]. In addition, intraop-
erative hyperglycemia was found to be an independent
risk factor for complications following cardiac surgery
[12]. Although a recent study [14] revealed insulin ther-
apy has been shown to reduce morbidity in medical ICU
patients. This lends the importance of examining different
patient populations who may be at risk for hyperglyc-
emia.
Most nurse initiated protocols identified thus far in the lit-
erature have a component where the RN needs to perform
some method of calculation to derive the insulin rate to
be infused [16-18,21,22]. The use of our non-calculated
IIP in this study, contributes to the safety and standardiza-
tion of the protocol. It appears our 4-column protocol
adapts to glucose sensitive and resistant patients in a sim-
ilar way in multiple patient populations. In addition, use
of a nurse initiated IIP has significant impact on nursing
practice by demonstrating decision making and critical
thinking skills by the RN in the care of the critically ill
patient.
The concern regarding the risk of hypoglycemia with
intensive insulin protocols has limited the expansion to
general care areas. However, the incidence of severe
hypoglycemia ( < 40 mg/dL) of patients on a protocol was
similar in both critical care (4%) and non-critical care
(3.6%) areas [20]. In addition, hypoglycemia ( < 45 mg/
dL) was not associated with mortality, although noted to
be a small study [26]. A systematic review of twenty-four
reports suggest that tight glucose control protocols main-
tained adequate glycemic control and resulted in low fre-
quencies of hypoglycemia [23]. Our study also had a more
conservative definition of hypoglycemia ( < 60 mg/dL)
with similar incidence across the 3 ICUs. Survivors within
the 48 hours after IIP discontinuation or patient transfer,
patients had significant increase in mean percent of blood
glucose values > 150 mg/dL (p < 0.0001). Given limited
hypoglycemia risks and our results related to hyperglyc-
emia after protocol discontinuation or patient transfer, it
would seem prudent to research the use of IIP in general
care areas and explore this transition further.
Table 4: Forty-eight hours after insulin infusion protocol discontinued or patient transfer
STICU (n = 149) MICU (n = 99) CCU (n = 83) p Value
Mean percent of BG > 150 
mg/dL, mean (SD)
26 (28) 43 (32) 38 (29) < 0.0001
BG measurements, mean 
(SD)
n = 1926 n = 1322 n = 986
17.5 (17.0) 15.2 (13.9) 13.5 (10.7) 0.02
BG, mean (SE)*, mg/dL 142 (3.6) 167 (4.4) 160 (4.8) < 0.0001
BG, blood glucose; SE, standard error
*To account for multiple values measured per person
Median & interquartile range of actual blood glucose values  of patients who underwent insulin infusion after admission- CCU Figure 6
Median & interquartile range of actual blood glucose 
values of patients who underwent insulin infusion 
after admission-CCU. The box plots indicate the distribu-
tion of the individual patient means. See statistical methods 
section for details.BMC Emergency Medicine 2007, 7:14 http://www.biomedcentral.com/1471-227X/7/14
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The investigators acknowledge several limitations with
this study. It was conducted in one setting with a lack of
randomized, controlled design. There were patient differ-
ences between and within population groups that were
not controlled for and a convenience sample of patients
who met inclusion criteria was utilized. We acknowledge
variability with utilizing three different types of blood glu-
cose measurements. At the time of the study, common
practice was to perform measurement with a capillary
sample. Extreme values (BG > 400 mg/dL and < 60 mg/
dL) were verified with an additional venous or arterial
sample. We have subsequently changed to utilizing arte-
rial samples, when arterial line is in place. We only use
capillary blood glucose in occasions of no arterial line,
based on ours and others analysis of variances in the
extremes of glucose levels associated with capillary analy-
sis [27]. In addition, there were different RNs implement-
ing and following the protocol and the demographic and
transfer data was collected by different data collectors. The
lack of fidelity or integrity measures to assure nurses were
implementing the interventions accurately and reliably is
also recognized. Based on findings from this study related
to IIP safety, current research literature, and input from
physicians, pharmacists and nurses at our institution, a
revised 3-column IIP with a tighter goal range for blood
glucose levels of 80–130 mg/dL has been implemented
and is available for use in any adult ICU. Although it is
recognized that oversimplification of the initial 4-column
approach may lead to differentiation of outcomes in dif-
ferent populations.
Conclusion
The RN initiated IIP was effective and safe in achieving a
target glucose goal of 100–150 mg/dL in the surgical, car-
diac and medical ICUs in our institution. The key to suc-
cessful IIP use involved multidisciplinary team approach
of nurses, pharmacists, physicians and laboratory person-
nel. No further tailoring of this protocol is needed for use
amongst differing patient groups. Control of blood glu-
cose post IIP had marked variability suggesting the need
for further studies regarding protocolized glucose control
of patients transitioning out of the ICU.
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